Aster DM Healthcare Ltd

Aster DM Health. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Aster DM Healthcare Ltd

₹ 348 -0.51%
03 Jul 10:55 a.m.
asterdmhealthcare.com BSE: 540975 NSE: ASTERDM
About

Aster DM Healthcare Limited is one of the largest integrated private healthcare service providers operating in GCC (Gulf Cooperation Council) countries and an emerging player in India. With an inherent emphasis on clinical excellence, it is one of the few entities in the world with a strong presence across primary, secondary, tertiary and quaternary healthcare. [1]

Key Points

Demerger[1]
The company is demerging its GCC and India operations into separate entities for operational efficiencies. Post-segregation, Aster DM Healthcare Limited will be focused on India business. The GCC Business will be separated from Aster DM Healthcare Limited to create Aster GCC. GCC Business will be acquired by Alpha GCC Holdings Limited for Enterprise Value of US$1,651.2m (~Rs. 13,540 crs). At the closing of the Transaction, Fajr Capital & its consortium members will own ~65% and a Promoter entity will own the remaining ~35% stake in the GCC Business through Aster GCC. The transaction is expected to complete by Q4 FY24.

Website BSE NSE
  • Market Cap ₹ 17,383 Cr.
  • Current Price ₹ 348
  • High / Low ₹ 558 / 294
  • Stock P/E 111
  • Book Value ₹ 66.0
  • Dividend Yield 0.58 %
  • ROCE 6.90 %
  • ROE 5.19 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company is expected to give good quarter
  • Company has delivered good profit growth of 27.4% CAGR over last 5 years
  • Company's median sales growth is 37.4% of last 10 years

Cons

  • Stock is trading at 5.30 times its book value
  • Company has a low return on equity of 5.00% over last 3 years.
  • Promoters have pledged 98.9% of their holding.
  • Working capital days have increased from 80.2 days to 255 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Healthcare Industry: Healthcare

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024
234.43 252.12 278.54 295.02 290.79 327.68 377.96 398.64 429.46 457.23 509.21 524.50 545.56
223.41 231.79 241.43 245.96 246.79 271.93 301.42 328.00 344.00 374.21 423.15 433.00 446.06
Operating Profit 11.02 20.33 37.11 49.06 44.00 55.75 76.54 70.64 85.46 83.02 86.06 91.50 99.50
OPM % 4.70% 8.06% 13.32% 16.63% 15.13% 17.01% 20.25% 17.72% 19.90% 18.16% 16.90% 17.45% 18.24%
6.39 7.40 13.38 6.88 54.54 9.08 17.77 10.69 12.23 11.49 20.48 13.33 3.72
Interest 8.90 10.50 10.25 11.85 11.42 10.98 12.07 14.18 14.58 15.64 20.72 21.09 20.92
Depreciation 22.01 24.65 24.85 24.75 24.47 23.97 25.28 25.71 29.06 26.05 29.13 30.55 35.65
Profit before tax -13.50 -7.42 15.39 19.34 62.65 29.88 56.96 41.44 54.05 52.82 56.69 53.19 46.65
Tax % -5.48% 0.00% 0.00% 0.00% -0.35% 0.00% 0.00% 16.55% 4.03% 0.00% -4.18% 0.00% 117.38%
-14.24 -7.42 15.39 19.34 62.87 29.88 56.96 34.58 51.87 52.82 59.06 53.19 -8.11
EPS in Rs -0.29 -0.15 0.31 0.39 1.26 0.60 1.14 0.69 1.04 1.06 1.18 1.06 -0.16
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
1 1 53 189 380 530 595 760 747 1,116 1,534 2,036
8 12 114 227 427 519 554 686 704 963 1,240 1,676
Operating Profit -7 -11 -60 -38 -47 12 41 74 42 153 293 360
OPM % -762% -1,256% -114% -20% -12% 2% 7% 10% 6% 14% 19% 18%
10 86 40 51 390 14 83 113 21 82 50 49
Interest 0 3 34 135 228 54 11 33 36 47 56 78
Depreciation 1 1 22 48 68 59 64 89 95 99 104 121
Profit before tax 2 72 -77 -170 47 -87 49 65 -68 90 182 209
Tax % 0% 2% -1% 0% 0% 0% 1% 6% -1% -0% 5% 25%
2 70 -78 -170 47 -87 48 61 -69 90 173 157
EPS in Rs 0.15 1.86 -2.00 -4.21 1.16 -1.73 0.95 1.21 -1.38 1.81 3.47 3.14
Dividend Payout % 0% 89% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: 117%
5 Years: 28%
3 Years: 40%
TTM: 33%
Compounded Profit Growth
10 Years: 8%
5 Years: 27%
3 Years: 63%
TTM: -10%
Stock Price CAGR
10 Years: %
5 Years: 23%
3 Years: 31%
1 Year: 7%
Return on Equity
10 Years: -1%
5 Years: 3%
3 Years: 5%
Last Year: 5%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity Capital 125 375 389 403 403 505 505 497 497 500 500 500
Reserves 343 103 209 535 1,925 2,421 2,475 2,434 2,367 2,081 2,257 2,795
Preference Capital 0 0 0 0 0 0 0 0 0 374 374
22 266 384 1,914 645 110 125 349 417 521 697 841
9 24 124 168 251 257 271 273 307 661 649 402
Total Liabilities 499 768 1,105 3,021 3,224 3,293 3,376 3,552 3,589 3,762 4,102 4,538
36 37 469 547 714 772 753 1,016 1,009 1,013 1,008 1,333
CWIP 123 287 100 130 63 17 70 20 11 23 67 39
Investments 227 266 317 2,037 2,137 2,086 2,095 2,150 2,151 2,166 2,141 2,176
114 178 219 307 309 417 458 366 418 560 886 990
Total Assets 499 768 1,105 3,021 3,224 3,293 3,376 3,552 3,589 3,762 4,102 4,538

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
-51 -3 -51 98 42 78 246 413
-251 -18 -36 40 -38 -49 -332 -342
222 95 7 -126 -12 -18 92 -67
Net Cash Flow -80 74 -80 12 -9 11 6 3

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 365 742 41 28 24 21 22 21 21 20 26 23
Inventory Days 171 100 66 42 38 49 38 32 38 39
Days Payable 288 150 102 57 64 240 270 173 228 200
Cash Conversion Cycle 365 742 -75 -22 -13 6 -4 -170 -210 -122 -163 -139
Working Capital Days 1,604 4,109 -59 -48 77 29 86 -45 -40 -22 8 255
ROCE % 0% 12% -5% -4% -4% -1% 2% 3% -1% 4% 7%

Shareholding Pattern

Numbers in percentages

9 Recently
Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
37.88% 37.88% 37.88% 37.88% 37.88% 37.88% 37.88% 41.88% 41.88% 41.88% 41.88% 41.88%
8.69% 10.80% 10.95% 11.03% 11.44% 11.77% 42.49% 38.63% 38.82% 40.22% 41.00% 33.48%
9.64% 8.48% 8.45% 8.64% 9.66% 8.99% 8.93% 8.93% 8.62% 7.64% 7.15% 13.70%
43.30% 42.36% 42.24% 41.99% 40.57% 40.91% 10.25% 10.12% 10.26% 9.85% 9.61% 10.59%
0.49% 0.48% 0.47% 0.46% 0.45% 0.45% 0.44% 0.43% 0.42% 0.41% 0.37% 0.35%
No. of Shareholders 94,00687,80480,74680,42778,37480,91384,57382,12971,37967,67367,33180,931

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls